(57 days)
Not Found
No
The summary describes a standard contact lens made of a hydrophilic polymer. There is no mention of any computational or analytical capabilities that would suggest the use of AI or ML. The focus is on the material composition, manufacturing process, and intended use for vision correction.
No.
The contact lens is indicated for the correction of visual acuity (myopia and hyperopia) and for cosmetic purposes (altering eye color), rather than for treating a disease or therapeutic condition.
No
This device is a contact lens intended for correcting visual acuity (myopia and hyperopia), enhancing or altering eye color, and not for diagnosing a disease or condition.
No
The device description clearly indicates it is a physical contact lens made of polymacon, a hydrophilic polymer, and does not mention any software components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The AQUASPLASH contact lens is a medical device intended for the correction of visual acuity and to enhance or alter the apparent color of the eye. It is worn directly on the eye.
- Lack of Biological Sample Analysis: The description does not mention any analysis of biological samples from the patient. The device itself is the therapeutic and cosmetic product.
Therefore, the AQUASPLASH contact lens falls under the category of a medical device, specifically a contact lens, and not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is indicated for daily wear for the correction of visual acuity in aphakic and non-aphakic persons with non-diseased eyes with myopia and hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 3.00 diopters or less. The lens is available clear or colored and may be used to enhance or alter the apparent color of the eye.
Eye care practitioners may prescribe the lens for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system. Eye care practitioners may prescribe the lens for single use daily disposable wear. When prescribed for daily disposable wear the lens is to be discarded after each removal.
Product codes
LPL, MVN
Device Description
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is a hydrophilic polymer of 2-hydroximethyl methacrylate (HEMA) cross-linked with Ethylene glycol dimethylacrylate (EGDMA) and water. When hydrated the lens consists of 62.0% polymacon and 38.0% water by weight when immersed in saline solution. The (polymacon) name has been adopted by the United States Adopted Names Council (USAN).
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lenses are available tinted for visibility or color printed to enhance or alter the apparent color of the eye. The lenses are processed to incorporate the 'listed' color additives and contain only the amount of the additive needed to accomplish the intended coloring effect. The lenses contain one or a combination of one or more of the following 'listed' color additives:
Color Additive | Listing |
---|---|
Titanium Dioxide | 21 CFR § 73.3126 |
Iron Oxide | 21 CFR § 73.3125 |
D&C Yellow No. 10 | 21 CFR § 73.3110 |
C.I. Pigment Violet 23 | 21 CFR § 73.3107 |
C.I. Pigment Green 7 | 21 CFR § 73.3124 |
When producing the color lenses, the manufacturing process changes the specifications to the clear contact lens by pad-printing the color pigment(s)-entrapping the colorants in the interpenetrating network of the contact lens material in a location that corresponds to the iris. The color pigments used are not removed by lens handling and cleaning/disinfecting procedures. Except for affecting the amount of light transmittance through the lens, the coloring process does not alter the original characteristics of the pre-tinted lens.
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is manufactured in sphere and toric design configurations. The material properties and available parameters of the finished lenses are as follows:
Parameter | Range | Tolerance |
---|---|---|
Chord Diameter | 13.5 mm to 14.5 mm | ±0.20 mm |
Center Thickness | 0.03 mm to 0.50 mm | When ≤ 0.10 mm → ±0.010 mm + 10% |
When > 0.10 mm → ±0.015 mm + 5% | ||
Base Curve | 8.30 mm to 9.0 mm | ±0.20 mm |
Back Vertex Power (F'v) | +10.00D to -10.00D | |
(in 0.25D steps) | When 0.00 1.50 D → ± 5° | |
Surface Appearance | - | Lenses should be clear with no surface defect |
Oxygen Permeability | ||
(x 10-11(cm²/sec)(mlO2)/(ml | ||
x mmHg)) | 9.77 | ±20% |
Light Transmission | ||
(@ 380-780nm) | >90% | ±5% |
Water Content | 38% | ±2% |
Refractive Index | 1.428 (hydrated) | ±0.005 |
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Eyes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eye care practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Performance Testing:
Bench testing was performed to verify the ability to manufacture the AQUASPLASH (polymacon) finished toric contact lenses to a variety of prescribed parameters within manufacturing tolerances.
Clinical Testing:
Clinical testing is not required. The clinical performance of soft (hydrophilic) contact lenses manufactured from polymacon materials has been demonstrated previously.
Key Results:
The data were determined to be scientifically valid under 21 CFR 860.7.
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is as safe and effective as the predicate device when used in accordance with the labeled directions for use and for the proposed indication.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
April 27, 2021
VP Optics % Bret Andre Principal Consultant EyeReg Consulting Inc. 6119 Canter Lane West Linn, OR 97068
Re: K210609
Trade/Device Name: AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: Class II Product Code: LPL, MVN Dated: February 24, 2021 Received: March 1, 2021
Dear Bret Andre:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safetyreporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-devicereporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
J. Angelo Green, Ph.D. Assistant Director DHT1A: Division of Ophthalmic Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K210609
Device Name
AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens
Indications for Use (Describe)
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is indicated for daily wear for the correction of visual acuity in aphakic and non-aphakic persons with non-diseased eyes with myopia and hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 3.00 diopters or less. The lens is available clear or colored and may be used to enhance or alter the apparent color of the eye.
Eye care practitioners may prescribe the lens for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system. Eye care practitioners may prescribe the lens for single use daily disposable wear. When prescribed for daily disposable wear the lens is to be discarded after each removal.
Type of Use (Select one or both, as applicable) | |
---|---|
------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: K210609
I. SUBMITTER
- February 24th, 2021 Date Prepared: VP OPTICS Name: Address: D-611, 17, Techno 4-ro, Daejeon, Yuseong-gu, Korea Contact Person: Daniel Yoon President Phone number: +82 507 1404 1026
- Bret Andre Consultant: EyeReg Consulting, Inc. 6119 Canter Ln. West Linn, OR 97068 Phone number: (503) 372-5226
II. DEVICE
| Trade Name: | AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact
Lens |
|-------------------------|----------------------------------------------------------------------|
| Common
Name: | Contact Lens, Daily Wear |
| Classification
Name: | Soft (hydrophilic) Contact Lens (21 CFR 886.5925) |
| Regulatory
Class: | Class II |
| Product Code: | LPL; MVN |
Purpose of 510(k) Submission:
~ New Device ~
4
III. PREDICATE DEVICE
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is substantially equivalent to the following predicate device:
- l "Neo Cosmo (Polymacon) Soft (Hydrophilic) Contact Lens" By NEO VISION CO., LTD. 510(k) number: K142275 Primary Predicate
IV. DEVICE DESCRIPTION
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is a hydrophilic polymer of 2-hydroximethyl methacrylate (HEMA) cross-linked with Ethylene glycol dimethylacrylate (EGDMA) and water. When hydrated the lens consists of 62.0% polymacon and 38.0% water by weight when immersed in saline solution. The (polymacon) name has been adopted by the United States Adopted Names Council (USAN).
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lenses are available tinted for visibility or color printed to enhance or alter the apparent color of the eye. The lenses are processed to incorporate the 'listed' color additives and contain only the amount of the additive needed to accomplish the intended coloring effect. The lenses contain one or a combination of one or more of the following 'listed' color additives:
Color Additive | Listing |
---|---|
Titanium Dioxide | 21 CFR § 73.3126 |
Iron Oxide | 21 CFR § 73.3125 |
D&C Yellow No. 10 | 21 CFR § 73.3110 |
C.I. Pigment Violet 23 | 21 CFR § 73.3107 |
C.I. Pigment Green 7 | 21 CFR § 73.3124 |
When producing the color lenses, the manufacturing process changes the specifications to the clear contact lens by pad-printing the color pigment(s)-entrapping the colorants in the interpenetrating network of the contact lens material in a location that corresponds to the iris. The color pigments used are not removed by lens handling and cleaning/disinfecting procedures. Except for affecting the amount of light transmittance through the lens, the coloring process does not alter the original characteristics of the pre-tinted lens.
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is manufactured in sphere and toric design configurations. The material properties and available parameters of the finished lenses are as follows:
5
Parameter | Range | Tolerance |
---|---|---|
Chord Diameter | 13.5 mm to 14.5 mm | ±0.20 mm |
Center Thickness | 0.03 mm to 0.50 mm | When ≤ 0.10 mm → ±0.010 mm + 10% |
When > 0.10 mm → ±0.015 mm + 5% | ||
Base Curve | 8.30 mm to 9.0 mm | ±0.20 mm |
Back Vertex Power (F'v) | +10.00D to -10.00D | |
(in 0.25D steps) | When 0.00 $ 1.50 D → ± 5° | |
Surface Appearance | - | Lenses should be clear with no surface defect |
Oxygen Permeability | ||
(x 10-11(cm²/sec)(mlO2)/(ml | ||
x mmHg)) | 9.77 | ±20% |
Light Transmission | ||
(@ 380-780nm) | >90% | ±5% |
Water Content | 38% | ±2% |
Refractive Index | 1.428 (hydrated) | ±0.005 |
V. INDICATIONS FOR USE
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is indicated for daily wear for the correction of visual acuity in aphakic persons with non-diseased eyes with myopia and hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 3.00 diopters or less. The lens is available clear or colored and may be used to enhance or alter the apparent color of the eye.
Eye care practitioners may prescribe the lens for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system. Eye care practitioners may prescribe the lens for single use daily disposable wear. When prescribed for daily disposable wear the lens is to be discarded after each removal.
6
VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH PREDICATE DEVICE
The AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens is substantially equivalent to the primary predicate device identified (K142275) regarding the following features:
- USAN contact lens material (polymacon)
- ! FDA category - Group I
- ! FDA classification - Soft (hydrophilic) Contact Lens (21 CFR 886.5925)
- ! Intended use - daily wear contact lenses
- 트 Actions
- ! Cast molded production method
- ! Injection molded polypropylene blister packaging
The following matrix illustrates the production method, lens function and material characteristics of the AQUASPLASH (Polymacon) Soft (Hydrophilic) Daily Wear Contact Lens, as well as the predicate device.
| | VP Optics
Aquasplash
(Subject Device) | NEO VISION CO., LTD.
Neo Cosmo
(K142275) |
|---------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|
| Intended Use | Daily wear,
Soft (hydrophilic) contact lens | Daily wear,
Soft (hydrophilic) contact lens |
| Actions | The contact lenses act as a refractive
medium that focus light rays from near and
distant objects on the retina | The contact lenses act as a refractive medium
that focus light rays from near and distant
objects on the retina |
| FDA Classification | Soft (hydrophilic) Contact Lens (21 CFR
886.5925) | Soft (hydrophilic) Contact Lens (21 CFR
886.5925) |
| FDA Group | FDA Group 1
(